Bisphosphonates and osteonecrosis of the jaw: innocent association or significant risk?
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19088006.
- Also identified by DOI 10.3949/ccjm.75a.08014.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Published case series and systematic reviews have documented an association between bisphosphonates and osteonecrosis of the jaw. However, a cause-and-effect relationship has not been established, and most of the reported cases have been in patients with cancer who were receiving much higher doses than those used to treat osteoporosis or Paget disease of bone. The risk, if any, to patients with these latter conditions receiving these drugs appears to be very small.